Context: Staphylococcus aureus is one of the most important pathogens worldwide. The emergence of methicillin-resistant Staphylococcusaureus (MRSA) made vancomycin as the only therapeutic choice. Due to excessive use of vancomycin, decreased susceptibility and increased resistance against this antibiotic are reported worldwide. The current study aimed at investigating the emergence of vancomycin-resistant Staphylococcus aureus (VRSA) in different regions of the Middle-East. Evidence Acquisition: All reputable databases, such as Google Scholar and PubMed, were screened for articles and abstracts reporting VRSA in the Middle-East by the appropriate keywords. Reliable phenotypic and genotypic studies were included in the current review. Results: Reviewing all articles/abstracts revealed more than 100 reports of VRSA isolates from the Middle-East. Most of the studies did not use the clinical and laboratory standards institute (CLSI) guidelines on VRSA identification. Until 2012, four VRSA strains were reported from Iran, 7 from Egypt, and 1 from Pakistan. From 2012 to 2016, seven VRSA isolates were added to the global statistics from the Middle-East; 1 from Iran and 6 from Egypt. Conclusions: VRSA is a global health threat. According to the expanding reports on the emersion of VRSA, more attention should be paid to the proper prescription of this antibiotic as the only choice for S. aureus infections.
Background & objectives:Staphylococcus aureus is one of the major causes of nosocomial infections. Recently, increase in its various drug-resistant strains, has increased health problems. Incidence of VRSA (vancomycin resistant Staphylococcus aureus) strains has created many concerns about the treatment of these bacterial infections. The aim of this study was to determine the frequency of Staphylococcus aureus with reduced susceptibility against vancomycinin clinical samples of patientsadmitted to the Ghaem and Imam Reza academic hospitals in Mashhad in 2014. Material and methods:In this cross-sectional study within 7 months, 176 S.aureus isolates obtained from clinical samples and were identified using the biochemical methods. To determine the resistance, the disk diffusion method according to CLSI (Clinical and Laboratory Standards Institute) guidelines was used. The minimum inhibitory concentration (MIC) was evaluated by the agar dilution method and approved by E.test. Results:Of 176 S.aureus isolates,68 strains (64/38%) were methicillin resistant.The results of the agar dilution method represented 55cases of VISA (vancomycin intermediate Staphylococcus aureus) and 6 cases VRSA. But, these results confirm the correct with E.Test standard tapes. Conclusion: Emergence of VISA and VRSA isolates has been limited treatment of infections. Therefore, clinicians must be aware of management of patients who are colonized or infected with VISA and VRSA
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.